LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Editorial: Drug discovery from natural sources: Animal venoms, plants, bacteria and fungi

Photo from wikipedia

Through several thousand million years of adaptive evolution, venomous animal species, toxic plants, and microorganisms have developed a large group of high-affinity and stable natural-based biomolecules, which have now been… Click to show full abstract

Through several thousand million years of adaptive evolution, venomous animal species, toxic plants, and microorganisms have developed a large group of high-affinity and stable natural-based biomolecules, which have now been isolated and identified. Some of these biomolecules can specifically bind to human receptors/ligands, which means they have a great potential to be used as novel prototype drug candidates for disease treatments such as hypertension, cancer, diabetes, drug-resistant bacterial infections etc. In the last 2 decades, a lot of studies have been focused on certain types of specific molecular targets on cells, which can be recognized by natural-based biomolecules, to unveil their use in different aspects of clinical prognosis and therapeutic applications. However, many natural-based prototype drugs entering clinical trials are still struggling because their modes of action are not fully identified. Thus, we must do more lab-based and preclinical work toward this research direction. In this Research Topic, we brought together leading researchers to exchange and share their findings on the hot topics of novel identified venom-based and plant-derived natural biomolecules with potent pharmacological activity and their corresponding molecular mechanisms to fulfil the gap which is hindering their potential use as novel prototype drug candidates for disease treatments such as cancer, hypertension, diabetes, anti-bacterial infection, and neurological disorders. An important aspect of this Research Topic is to unleash the anticancer potentials of the natural biomolecules such as cytotoxins and peptides. Chong et al. identified two cytotoxins fromNaja sumatrana (NS-CTX) andNaja kaouthia (NK-CTX), which were highly potent in inhibiting the growth of lung cancer cell lines selectively. Chong’s research team further concluded that these cobra cytotoxins have such potential; however, their highly evolved and diet-adapted cytotoxic nature might have limited the intended application as a safe and effective drug. From their study, the data underscores the need for a comprehensive, fundamental investigation that addresses the selectivity and cell death mechanism of OPEN ACCESS

Keywords: drug discovery; natural based; editorial drug; discovery natural; drug; research

Journal Title: Frontiers in Molecular Biosciences
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.